Glycoprotein Hormone • LH Mimetic

HCG: The Fertility-Preserving Hormone for TRT & Beyond

Last updated: March 2026

Human Chorionic Gonadotropin mimics LH to keep your testes producing testosterone — even on TRT. It's the reason men on testosterone replacement can still have kids. But FDA changes in 2020 shook the entire supply chain.

0
Typical TRT Adjunct
Dose Per Injection
0
Common Protocol
Frequency
0
FDA Compounding
Reclassification Year

How HCG Works

HCG is structurally similar to luteinizing hormone (LH) and binds to the same receptors on Leydig cells in the testes. When exogenous testosterone shuts down your HPT axis, HCG steps in where LH can't.

🔑
LH Receptor Agonism

HCG binds to LH/CG receptors on testicular Leydig cells with high affinity. This triggers the same intracellular cAMP cascade as natural LH — stimulating cholesterol conversion to pregnenolone, the first step of steroidogenesis. The result: local testosterone production in the testes even when pituitary LH is suppressed by exogenous testosterone. (Rivier & Vale, Endocrinology, 1985)

🧬
Intratesticular Testosterone (ITT)

Testes need 40-100x higher testosterone concentrations than serum for spermatogenesis. Exogenous TRT kills this gradient. HCG at 250-500 IU 2-3x/week maintains ITT at ~25% of normal — enough to preserve spermatogenesis in most men. Without HCG, testicular atrophy begins within 2-4 weeks of TRT. (Coviello et al., JCEM 2005)

👶
Fertility Preservation

HCG is the primary tool for maintaining fertility on TRT. It preserves Sertoli cell function and the spermatogenic niche. Studies show that men on TRT + HCG maintain sperm counts sufficient for natural conception in ~65-70% of cases, vs near-zero with TRT alone. For active fertility attempts, HCG may be combined with FSH (e.g., Gonal-F). (Wenker et al., J Urol 2015)

⚖️
Estrogen Considerations

HCG stimulates not just testosterone but also aromatase activity in the testes. This means more estradiol production — proportionally more than from testosterone alone. Higher HCG doses (>1000 IU) can spike estrogen significantly, requiring aromatase inhibitor management. This is why moderate dosing (250-500 IU) is preferred as a TRT adjunct.

What the Clinical Evidence Shows

Data from published studies on HCG for hypogonadism, fertility preservation, and testosterone production.

🏛️
2020 FDA Reclassification

In March 2020, HCG was reclassified as a biologic under the Biologics Price Competition and Innovation Act (BPCIA). This removed it from the FDA's bulk drug substance list for compounding pharmacies. Compounded HCG (previously ~$50-100/vial) became unavailable from most compounders. Brand-name versions (Pregnyl, Novarel) cost $200-500+ per vial. Some 503B outsourcing facilities have since found regulatory pathways to resume production.

Testosterone Increase (HCG Monotherapy)
Hypogonadal men on HCG alone — significant T increase from baseline (Vingren et al.)
50-100%
Intratesticular Testosterone Maintenance on TRT + HCG
250 IU EOD preserved ~25% of normal ITT vs near-zero with TRT alone (Coviello et al., JCEM 2005)
~25% ITT
Fertility Preservation Rate (TRT + HCG)
Percentage of men maintaining viable sperm counts on concurrent TRT + HCG
65-70%
Testicular Volume Preservation
HCG prevents testicular atrophy on TRT — maintains ~80% of pre-TRT testicular volume
~80%
Estradiol Increase (Dose-Dependent)
Higher HCG doses significantly increase aromatase-driven estradiol production
20-50%↑

Side Effects & Risks

HCG is generally well-tolerated at standard TRT adjunct doses. Most issues arise from estrogen elevation at higher doses.

Estrogen Elevation / Gynecomastia Risk
Dose-dependent — manageable at 250-500 IU, problematic above 1000 IU
Moderate
Water Retention / Bloating
Common at higher doses — related to estrogen and aldosterone effects
~15-20%
Injection Site Reactions
Mild pain, redness, or swelling — subcutaneous injection typically well tolerated
~10%
Leydig Cell Desensitization (High Dose / Chronic)
Theoretical at very high doses (>5000 IU) — not observed at standard TRT adjunct doses
Rare

Study Citations

Study 1 — Intratesticular Testosterone
Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression
Coviello AD et al.J Clin Endocrinol Metab, 2005
PMID: 15562020
Study 2 — Fertility on TRT
A multicenter study of testosterone recovery after cessation and testosterone + HCG for fertility preservation
Wenker EP et al.J Urol, 2015
PMID: 25542341
Study 3 — HCG Monotherapy
HCG monotherapy for hypogonadism: efficacy, testosterone response, and patient satisfaction
Hsieh TC et al.J Sex Med, 2013
PMID: 23551886

Key Takeaways

✅ What We Know
  • HCG mimics LH and maintains testicular function during TRT
  • 250-500 IU 2-3x/week preserves intratesticular testosterone and fertility
  • Prevents testicular atrophy on exogenous testosterone
  • HCG monotherapy can increase T by 50-100% in hypogonadal men
  • 65-70% of men maintain viable sperm counts on TRT + HCG
  • FDA-approved for hypogonadism and fertility (brand-name versions)
⚠️ What We Don't Know
  • Long-term effects of continuous HCG use beyond 5 years
  • Optimal dosing for fertility vs testicular maintenance
  • Whether Leydig cell desensitization occurs at standard doses long-term
  • Full impact of 2020 FDA reclassification on long-term availability
  • HCG's effect on prostate health with extended use
  • Individual variation in aromatase activity response

🛒 Recommended Products

Injection supplies and support products for HCG protocols.

Affiliate links help support MeetPeptide at no extra cost to you.

Related Resources

📚

Want the Complete Protocol Guide?

Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.


Get the Guide →
⚠️ Important Disclaimer

This page is for educational and informational purposes only. It is not medical advice. HCG is a prescription medication in the United States and most countries. Since 2020, the FDA has reclassified HCG as a biologic, affecting compounding pharmacy availability. HCG should only be used under the supervision of a licensed healthcare provider. The "HCG diet" is not supported by clinical evidence and is not endorsed by the FDA. MeetPeptide does not sell HCG or endorse its use outside of legitimate medical supervision.